MedPath
NMPA Approval

Ossotide Injection

国药准字H53022164

September 18, 2020

国药准字H53022164

Drug Information

骨肽注射液

注射剂

2ml:10mg

化学药品

September 18, 2020

Company Information

Applicant Company

Manufacturing Company

云南省大理白族自治州大理市大理经济开发区生物制药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

骨肽注射液 - NMPA 批准文号 | MedPath